Christopher King

3.9k total citations · 1 hit paper
82 papers, 2.6k citations indexed

About

Christopher King is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Christopher King has authored 82 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 29 papers in Radiation and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Christopher King's work include Prostate Cancer Diagnosis and Treatment (38 papers), Prostate Cancer Treatment and Research (33 papers) and Advanced Radiotherapy Techniques (29 papers). Christopher King is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (38 papers), Prostate Cancer Treatment and Research (33 papers) and Advanced Radiotherapy Techniques (29 papers). Christopher King collaborates with scholars based in United States, United Kingdom and Canada. Christopher King's co-authors include Kalina Hristova, Debra Freeman, Joseph C. Presti, Harcharan Gill, James D. Brooks, Michael T. Spiotto, Gary Luxton, Valerică Raicu, Paul Keall and Jennifer Lippincott‐Schwartz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Christopher King

79 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Outcomes From a Prospective Trial of Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer

2011 314 citations Christopher King, Joseph C. Presti et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher King United States	26	1.6k	1.1k	525	468	255	82	2.6k
Zvi Fuks United States	19	2.0k 1.2×	1.9k 1.7×	1.2k 2.4×	1.1k 2.4×	257 1.0×	22	3.7k
Shigeaki Ogura Japan	21	961 0.6×	509 0.4×	418 0.8×	329 0.7×	142 0.6×	52	1.9k
Fiona McDonald United Kingdom	30	1.2k 0.7×	661 0.6×	707 1.3×	374 0.8×	339 1.3×	131	2.4k
Mitsuyuki Abe Japan	35	1.6k 1.0×	675 0.6×	837 1.6×	456 1.0×	766 3.0×	155	3.8k
Darko Pucar United States	22	1.1k 0.7×	151 0.1×	762 1.5×	679 1.5×	209 0.8×	67	2.4k
Daniel Habermehl Germany	35	1.4k 0.9×	821 0.7×	601 1.1×	323 0.7×	793 3.1×	115	3.0k
Virginie Monceau France	16	974 0.6×	777 0.7×	487 0.9×	396 0.8×	76 0.3×	28	1.7k
Peter J.C.M. Nowak Netherlands	27	1.1k 0.7×	1.1k 1.0×	1.1k 2.0×	96 0.2×	364 1.4×	55	2.6k
Hubert Thierens Belgium	38	1.5k 0.9×	1.5k 1.3×	1.8k 3.5×	966 2.1×	210 0.8×	152	4.2k
Lennart Johansson Sweden	22	414 0.3×	397 0.3×	663 1.3×	375 0.8×	140 0.5×	105	1.8k

Countries citing papers authored by Christopher King

Since Specialization

Citations

This map shows the geographic impact of Christopher King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher King more than expected).

Fields of papers citing papers by Christopher King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher King. The network helps show where Christopher King may publish in the future.

Co-authorship network of co-authors of Christopher King

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher King. A scholar is included among the top collaborators of Christopher King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher King. Christopher King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhatt, Nitin, et al.. (2023). DERIVATION OF A SIMPLE RISK CALCULATOR FOR PREDICTING CLINICAL WORSENING IN PATIENTS WITH PULMONARY HYPERTENSION DUE TO INTERSTITIAL LUNG DISEASE. CHEST Journal. 164(4). A5862–A5863. 1 indexed citations

King, Christopher, Prabuddha Sengupta, Arnold Y. Seo, & Jennifer Lippincott‐Schwartz. (2020). ER membranes exhibit phase behavior at sites of organelle contact. Proceedings of the National Academy of Sciences. 117(13). 7225–7235. 123 indexed citations

Singh, Deo R., et al.. (2019). Revisiting a controversy: The effect of EGF on EGFR dimer stability. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1862(1). 183015–183015. 13 indexed citations

King, Christopher, et al.. (2018). Interactions between NRP1 and VEGFR2 molecules in the plasma membrane. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1860(10). 2118–2125. 20 indexed citations

Singh, Deo R., Pranjali Kanvinde, Christopher King, Elena B. Pasquale, & Kalina Hristova. (2018). The EphA2 receptor is activated through induction of distinct, ligand-dependent oligomeric structures. Communications Biology. 1(1). 15–15. 66 indexed citations

Johnson, Skyler B., Pamela R. Soulos, Timothy D. Shafman, et al.. (2016). Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E242–E242. 1 indexed citations

King, Christopher, Sarvenaz Sarabipour, Patrick O. Byrne, Daniel J. Leahy, & Kalina Hristova. (2014). The FRET Signatures of Noninteracting Proteins in Membranes: Simulations and Experiments. Biophysical Journal. 106(6). 1309–1317. 76 indexed citations

Nathan, Steven D. & Christopher King. (2014). Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?. Drug Design Development and Therapy. 8. 875–875. 16 indexed citations

Sarabipour, Sarvenaz, Christopher King, & Kalina Hristova. (2014). Uninduced high-yield bacterial expression of fluorescent proteins. Analytical Biochemistry. 449. 155–157. 28 indexed citations

10.

King, Christopher. (2013). Adjuvant Versus Salvage Radiotherapy for High-Risk Prostate Cancer Patients. Seminars in Radiation Oncology. 23(3). 215–221. 30 indexed citations

11.

King, Christopher. (2012). Adjuvant Versus Salvage Radiotherapy After Prostatectomy: The Apple Versus the Orange. International Journal of Radiation Oncology*Biology*Physics. 82(3). 1045–1046. 10 indexed citations

12.

Wiegner, E. & Christopher King. (2010). Sexual Function After Stereotactic Body Radiotherapy for Prostate Cancer: Results of a Prospective Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 78(2). 442–448. 58 indexed citations

13.

Adler, Peter H., et al.. (2009). Hypothermia: An Unusual Indication for Gastric Lavage. Journal of Emergency Medicine. 40(2). 176–178. 6 indexed citations

14.

Djajaputra, David, Yongzhi Xie, Christopher King, et al.. (2008). Intra-fractional Motion of the Prostate during Protracted Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 72(1). S352–S353. 1 indexed citations

15.

King, Christopher, Michael T. Spiotto, & Daniel S. Kapp. (2008). Obesity and Risk of Biochemical Failure for Patients Receiving Salvage Radiotherapy After Prostatectomy. International Journal of Radiation Oncology*Biology*Physics. 73(4). 1017–1022. 13 indexed citations

16.

Prescott, R., I. Kunkler, Letitia Williams, et al.. (2007). A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. Health Technology Assessment. 11(31). 1–149, iii. 87 indexed citations

17.

King, Christopher, Stephen J. Freedland, Martha K. Terris, et al.. (2007). Impact of Obesity on the Utility of Preoperative Prostate-Specific Antigen Velocity to Predict for Relapse After Prostatectomy: A Report from the SEARCH Database. Urology. 69(5). 921–926. 9 indexed citations

18.

King, Christopher. (2002). LDR vs. HDR brachytherapy for localized prostate cancer. Brachytherapy. 1(4). 219–226. 43 indexed citations

19.

King, Christopher. (2000). Patterns of prostate cancer biopsy grading:Trends and clinical implications. International Journal of Cancer. 90(6). 305–311. 92 indexed citations

20.

Nath, Ravinder, et al.. (1992). Development of a shielded 241Am applicator for continuous low dose rate irradiation of rat rectum. International Journal of Radiation Oncology*Biology*Physics. 23(1). 175–181. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact